Patents Assigned to Advanced Bioconcept Company
  • Patent number: 6680367
    Abstract: Light emitting compounds of the formula where R1 is a light-emitting moiety, R2 is a CRF-related peptide and fragment, derivative or analog thereof and L is a linker moiety, which may be present or absent. The peptide is linked at a first amino acid position to (C—X) which, in turn, is selected from the group including C═O, C═S, CH(OH), C═C═O, C═NH, CH2, CH(OR), CH(NR), CH(R), CR3R4, and C(OR3)OR4 where R, R3, and R4 are alkyl moieties or substituted alkyl moieties. Optionally the compound may include a linker moiety between the peptide and the C—X binding group. Preferably, the compound exhibits substantial biological activity in the presence of receptors having affinities for CRF-related peptides.
    Type: Grant
    Filed: July 19, 1999
    Date of Patent: January 20, 2004
    Assignee: Advanced Bioconcept Company
    Inventors: Clarissa Desjardins, Jacek Slon-Usakiewicz, Katherine J. Bonter
  • Patent number: 6677430
    Abstract: Light emitting compounds of the formula: where R1 is a light-emitting moiety and R2 is a motilin peptide and fragment, derivative or analog thereof The peptide is linked at a first amino acid position to (C—X) which, in turn, is selected from the group including C═O, C═S, CH(OH), C═C═O, C═NH, CH2, CH(OR), CH(NR), CH(R), CR3R4, and C(OR3)OR4 where R, R3, and R4 are alkyl moieties or substituted alkyl moieties. Optionally the compound may include a linker moiety between the peptide and the C—X binding group. Preferably, the compound exhibits substantial biological activity in the presence of receptors having affinities for motilin peptides.
    Type: Grant
    Filed: March 31, 2000
    Date of Patent: January 13, 2004
    Assignee: Advanced Bioconcept Company
    Inventors: Clarissa Desjardins, Jacek Slon-Usakiewicz, Katherine J. Bonter